BLCO$20.030.10%0.02
Bausch Lomb Corp (BLCO)
Date: 2026-11-03 16:00O: 19.86H: 20.07L: 19.77C: 20.03Vol: 682.6k
Bausch Lomb Corp stock is traded at $20.03, with a volume of 682,628. It is up +0.10% in the last 24 hours and up +17.07% over the past month. Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
Previous Close:
$20.01
Open:
$19.86
24h Volume:
682,628
Relative Volume:
0.51
Market Cap:
$7.16B
Revenue:
$5.21B
Net Income/Loss:
-$211.00M
P/E Ratio:
-
EPS:
-$0.6179
Net Cash Flow:
$861.30K
1W Performance:
-1.81%
1M Performance:
+17.07%
6M Performance:
+22.88%
1Y Performance:
+33.53%
1-Day Range:
$0.00$0.00
1-Week Range:
$19.68$21.36
52-Week Range:
$14.44$21.36
Bausch Lomb Corp Stock (BLCO) Company Profile
Name
Bausch Lomb CorpSector
HealthcareIndustry
Medical Instruments & SuppliesPhone
908-541-5456Address
520 APPLEWOOD CRESCENT, VAUGHAN, CanadaMarket Cap
Revenue
Net Income
Cash Flow
EPS
Bausch Lomb Corp Stock (BLCO) Upgrades & Downgrades
Bausch Lomb Corp Stock (BLCO) Financials Data
Bausch Lomb Corp Stock (BLCO) Insider Trading
- Bernier Nathalie D.Nov 03 '26Former Director
- Transaction
- Proposed Sale
- Cost
- $19.88
- #Shares
- 40,022
- Value ($)
- 795,735
- #Shares Total
- 0
- Munsch FrederickOct 29 '26Officer
- Transaction
- Proposed Sale
- Cost
- $20.48
- #Shares
- 112,015
- Value ($)
- 2,294,349
- #Shares Total
- 0
- Munsch FrederickOct 29 '26SVP, Controller and CAO
- Transaction
- Sale
- Cost
- $20.48
- #Shares
- 112,015
- Value ($)
- 2,294,067
- #Shares Total
- 45,831
- Munsch FrederickOct 29 '26SVP, Controller and CAO
- Transaction
- Option Exercise
- Cost
- $17.99
- #Shares
- 112,015
- Value ($)
- 2,015,306
- #Shares Total
- 157,846
- Ling KarenSep 28 '26Former Director
- Transaction
- Proposed Sale
- Cost
- $16.83
- #Shares
- 4,500
- Value ($)
- 75,735
- #Shares Total
- 0
- Munsch FrederickAug 10 '26SVP, Controller and CAO
- Transaction
- Sale
- Cost
- $16.78
- #Shares
- 52,900
- Value ($)
- 887,662
- #Shares Total
- 45,831
- Munsch FrederickAug 10 '26Former Officer
- Transaction
- Proposed Sale
- Cost
- $16.78
- #Shares
- 52,900
- Value ($)
- 887,885
- #Shares Total
- 0
- VON ESCHENBACH ANDREW C.Aug 07 '26Director
- Transaction
- Sale
- Cost
- $16.58
- #Shares
- 6,059
- Value ($)
- 100,458
- #Shares Total
- 63,733
- VON ESCHENBACH ANDREW C.Aug 07 '26Former Director
- Transaction
- Proposed Sale
- Cost
- $16.58
- #Shares
- 6,059
- Value ($)
- 100,430
- #Shares Total
- 0
- VON ESCHENBACH ANDREW C.Aug 06 '26Director
- Transaction
- Sale
- Cost
- $16.50
- #Shares
- 12,500
- Value ($)
- 206,250
- #Shares Total
- 69,792
